Retracted: Diagnosis of Chronic Kidney Disease by Three-Dimensional Contrast-Enhanced Ultrasound Combined with Augmented Reality Medical Technology. [PDF]
J Healthc Eng, 2023 Healthcare Engineering JO.
europepmc +1 more source
Choosing between traditional and innovative technologies: the case of scientific uncertainty [PDF]
We study the choice between a traditional technology characterized by known risks and an innovative technology (a geological storages for nuclear wastes, a genetically modified organism or a new treatment in medical science) subject to scientific ...
Giovanni Immordino
core
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Current state of the art and future directions for implantable sensors in medical technology: Clinical needs and engineering challenges. [PDF]
APL Bioeng, 2023 Yogev D +5 more
europepmc +1 more source
Technology-enhanced Learning of Community Health in Undergraduate Medical Education [PDF]
, 2010 Kalyani Premkumar +5 more
openalex +1 more source
Technology and Medical Care in India: Growth of Telehealth Awareness during the COVID-19 Pandemic
, 2022 Ragul Ganesh +2 more
openalex +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Molecular Oncology, EarlyView.Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology. [PDF]
Appl Health Econ Health Policy, 2023 Davies H +6 more
europepmc +1 more source
Molecular Oncology, EarlyView.HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
Analysis and Forecast of Indicators Related to Medical Workers and Medical Technology in Selected Countries of Eastern Europe and Balkan. [PDF]
Healthcare (Basel), 2023 Stepovic M +6 more
europepmc +1 more source